Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress

心理教育 医学 焦虑 萧条(经济学) 生活质量(医疗保健) 苦恼 接受和承诺疗法 随机对照试验 置信区间 炎症性肠病 物理疗法 内科学 疾病 干预(咨询) 精神科 临床心理学 护理部 宏观经济学 经济
作者
Daniel A. Romano,Susan Chesterman,Matthew Fuller‐Tyszkiewicz,Subhadra Evans,Madeleine Dober,Richard Blair Gearry,Peter R. Gibson,Simon Robert Knowles,Andrew McCombie,O Eric,LISA S. OLIVE,Leanne Raven,Leesa Micole Van Niekerk,Antonina A Mikocka‐Walus
出处
期刊:Inflammatory Bowel Diseases [Oxford University Press]
卷期号:30 (6): 911-921 被引量:20
标识
DOI:10.1093/ibd/izad122
摘要

BACKGROUND: The bidirectional relationship between inflammatory bowel disease (IBD) flare-ups and depression/anxiety symptoms has prompted investigations into psychotherapy to improve health-related quality of life (HRQoL) by targeting depression and anxiety. Acceptance commitment therapy (ACT) is effective in improving symptoms of depression and anxiety in people with chronic diseases, yet minimal research has examined ACT's effectiveness for IBD. This study examines the feasibility, acceptability, and preliminary efficacy of the ACTforIBD program, an online program codesigned with consumers to deliver ACT to those with IBD. METHODS: Adults with IBD and symptoms of mild-moderate distress were randomized to ACTforIBD or an active control (psychoeducation) condition. Participants completed 8 weekly, 1-hour sessions, 4 of which were therapist facilitated. Feasibility was based on recruitment and retention and acceptability was derived from postprogram satisfaction measures. Preliminary efficacy was determined by group differences in rate of change in study outcomes from baseline to postprogram. RESULTS: Of 62 participants (89% women, 11% men; mean age 33 years), 55 completed the program (ACTforIBD: n = 26 [83.9%]; active control: n = 29 [93.5%]). Adherence and acceptability were high in the ACTforIBD group, with 80% of participants completing all self-directed modules and 78% of participants expressing satisfaction with the program. Significant and marginally significant group × time interactions were found for anxiety symptoms (b = -1.89; 95% confidence interval, -3.38 to -0.42) and psychological HRQoL (b = -0.04; 95% confidence interval, -0.07 to 0.01), showing decreased anxiety and increased psychological HRQoL in the intervention group. CONCLUSIONS: ACTforIBD is feasible, acceptable, and improved anxiety symptoms, and psychological HRQoL. This highlights the need for a full-scale randomized controlled trial to further examine the program's efficacy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
h11的应助被yy采纳,获得10
1秒前
1秒前
111完成签到,获得积分10
1秒前
章海鹏完成签到 ,获得积分10
1秒前
erhya完成签到,获得积分10
1秒前
顾矜的应助被王kk采纳,获得10
1秒前
华仔的应助被Rony采纳,获得10
1秒前
2秒前
hustzwqq完成签到,获得积分10
2秒前
典雅的雪晴完成签到,获得积分10
2秒前
2秒前
完美世界的应助被辉太狼采纳,获得10
2秒前
无敌淀粉肠完成签到,获得积分10
3秒前
虚幻的冷松完成签到,获得积分10
3秒前
冷酷以山发布了新的文献求助10
3秒前
VENTUS完成签到,获得积分10
3秒前
受伤的严青完成签到 ,获得积分10
4秒前
chen完成签到,获得积分10
4秒前
小蘑菇的应助被正直的的白羊采纳,获得10
4秒前
DavidChen完成签到,获得积分10
4秒前
4秒前
可乐完成签到,获得积分10
4秒前
Lychee完成签到,获得积分10
4秒前
Rocc完成签到,获得积分10
5秒前
一叶知秋完成签到,获得积分10
5秒前
星辰大海的应助被哈哈采纳,获得10
5秒前
科隆龙完成签到,获得积分10
5秒前
zzz完成签到,获得积分10
6秒前
阿怪12333完成签到,获得积分10
6秒前
细腻驳发布了新的文献求助10
6秒前
李多意发布了新的文献求助10
6秒前
Elias完成签到,获得积分10
7秒前
任性行天完成签到,获得积分10
7秒前
revew666完成签到,获得积分0
7秒前
Starain完成签到,获得积分10
7秒前
乔乔完成签到,获得积分10
8秒前
寻找论文的研究生a完成签到,获得积分10
8秒前
emberlynn完成签到,获得积分10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159212
求助须知:如何正确求助?哪些是违规求助? 9554678
关于积分的说明 21720538
捐赠科研通 7748887
什么是DOI,文献DOI怎么找? 3427184
关于科研通互助平台的介绍 2552092
邀请新用户注册赠送积分活动 2471464